RFK Jr. Could Prove a Surprise Boon for Stem-cell Stocks With Pivotal Year Ahead

MarketWatchDec 13 01:08

Stem Cells Poised for Success in 2025 as Regulatory Environment Looks More Favorable -- Market Talk

WSJDec 12 23:05

JonesTrading Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $40

Futu NewsDec 6 05:31 · Ratings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 6 05:05

America's Car-Mart Posts Upbeat Sales, Joins Methode Electronics, Verint Systems, Brown-Forman And Other Big Stocks Moving Higher On Thursday

BenzingaDec 5 23:15

Capricor Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswireDec 3 05:15